A large 2020 study concluded, Ozempic is associated with higher rates of diabetic retinopathy and adverse ocular events compared to other GLP-1 receptor agonists. Specifically: A 2020 study reviewing back to 2018 looked at 2,109 adverse events associated with Ozempic
This is similar to results found in other GLP-1s, which also ultimately lead to a weight-loss plateau
GLP-1s dont cure lipedema on their own, but they can help some people feel better day to day
Global, regional, and national burden of chronic kidney disease, 19902017: a systematic analysis for the Global Burden of Disease Study 2017
Stomach pain, diarrhea, and headaches are somewhat less common, happening in 1 to 2 percent of people who take it